Please note that this is archived content and may no longer reflect current information or practices
Download our new eBook below to discover how to efficiently access US investors. It covers key topics such as:
- The value companies gain by cross-trading in the US.
- Key considerations for companies when selecting the best methods for reaching US investors.
- Best-in-class case studies from Britvic, Orexo and BASF.
- The investor perspective – how it works: interview with Stefan Spath, managing director, MCAP Markets.
- The myths of cross-trading: common misconceptions you may have about regulation, disclosure requirements and more.
Please complete the form below with the information requested. Once you have filled in the form, you will receive or be taken to the white paper.
We need this information so that we can make the report available to you, and so that we and OTC Markets can keep you updated via email and telephone of our products and services.
Neither IR Magazine nor OTC Markets will share this information with any third parties, and will only process it in accordance with our respective privacy policies, available here: IR Magazine privacy policy and OTC Markets privacy policy.
You may choose to unsubscribe at any time by clicking on the “unsubscribe” link in any email communication from IR Magazine or OTC Markets.
>>
